Cheminformatic Tools and Databases for Pharmacology

session 60875 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
MAFODOTIN

BELANTAMAB MAFODOTIN-BLMF
MAFODOTIN


ATC L01XC39

ANTINEOPLASTIC
TREATMENT OF MULTIPLE MYELOMA
ANTIBODY-DRUG CONJUGATE (ADC)
MICROTUBULE INHIBITOR

INTRAVENOUS

Tmax 0.78 HOUR

VD 11 LITER

TUBULIN

Not determined at DrugCentralANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
SG3199

LONCASTUXIMAB TESIRINE-LPYL

ANTINEOPLASTIC
TREATMENT OF B-CELL LYMPHOMA
ANTIBODY-DRUG CONJUGATE (ADC) TARGETING CD19
PYRROLOBENZODIAZEPINE (PBD) DIMER CYTOTOXIC ALKYLAT ING AGENT

INJECTION

VD 7.11 LITER

DNA

Not determined at DrugCentralANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |